Breaking News Instant updates and real-time market news.

AAPL

Apple

$188.50

-3.73 (-1.94%)

12:17
11/14/18
11/14
12:17
11/14/18
12:17

Technical Take: Apple downside momentum picking up pace

The stock was last at $186.95. down over 2.7% on the session. At that price next support is at the $186 area and then at the $185 area. Resistance is at $189.22.

  • 14

    Nov

AAPL Apple
$188.50

-3.73 (-1.94%)

11/14/18
ADAM
11/14/18
NO CHANGE
Target $83
ADAM
Buy
Qorvo price target lowered to $83 from $90 at Canaccord
Canaccord analyst T. Michael Walkley lowered his price target on Qorvo (QRVO) to $83 from $90 after the company lowered its guidance, as several Apple (AAPL) suppliers have done. He expects Qorvo to continue focusing on developing integrated solutions to drive dollar content growth faster than the slow growing smartphone market and anticipates improving growth trends as 5G ramps long-term. Walkley reiterated his Buy rating on Qorvo shares.
11/14/18
DADA
11/14/18
NO CHANGE
Target $72
DADA
Neutral
Qorvo price target lowered to $72 from $81 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Qorvo (QRVO) to $72 and kept his Neutral rating after the company cut its Q3 earnings guidance to reflect the expectations of a weaker high-end smartphone demand. The analyst believes that the "softer than expected" launch of the new iPhones by Apple (AAPL) has " triggered a rapid change in order flow over the past couple of weeks" and anticipates similar announcements from other Apple suppliers to track reduced guidance by Qorvo and Lumentum (LITE).
11/14/18
LOOP
11/14/18
NO CHANGE
Target $85
LOOP
Buy
Qorvo price target lowered to $85 from $90 at Loop Capital
Loop Capital analyst Cody Acree lowered his price target on Qorvo (QRVO) to $85 after its reduced Q3 guidance, saying the "softer unit volumes" sold by Apple (AAPL) were "undoubtedly the primary unnamed specific cause". The analyst is keeping his Buy rating on the shares however, stating that the "tier-1 smartphone unit weakness is becoming a common theme" that is generating lesser impact with each news release as evidenced by Qorvo's shares trading flat yesterday. Acree adds that investors should start to "pick their spots for 2019" amid the smartphone industry's start of migration to 5G and believes that Qorvo is "well positioned to continue to gain share at the leading tier-1 handset OEMs".
11/14/18
11/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Guggenheim with analyst Robert Cihra saying the average selling price of the iPhone has increased a "dramatic" $220, or 40%, over the past 10 years, reflecting its "growing value to both consumer and business markets." 2. Kellogg (K) downgraded to Neutral from Overweight at JPMorgan with analyst Ken Goldman saying that while nothing at the company's investor day "necessarily disappointed" him, he also did not gain "much comfort that the bottom-line turnaround would be swift." 3. Apollo Global (APO) and Carlyle Group (CG) were downgraded to Equal Weight from Overweight at Morgan Stanley. 4. Conagra Brands (CAG) downgraded to Underperform from Market Perform at Bernstein with analyst Alexia Howard saying the frozen category has experienced positive growth over the past year, largely led by new product innovation from Conagra and Pinnacle Foods, but this now seems to be running out of steam. 5. Tenneco (TEN) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Armintas Sinkevicius citing its elevated leverage and limited free cash flow conversion in what he views as an increasingly uncertain environment for auto suppliers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DATA

Tableau

$119.33

0.82 (0.69%)

08:06
04/23/19
04/23
08:06
04/23/19
08:06
Recommendations
Tableau analyst commentary  »

Tableau price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    May

  • 21

    May

URGN

UroGen Pharma

$37.12

0.54 (1.48%)

, JNJ

Johnson & Johnson

$137.88

0.345 (0.25%)

08:05
04/23/19
04/23
08:05
04/23/19
08:05
Hot Stocks
UroGen Pharma announces early-stage feasibility agreement with Janssen »

UroGen Pharma (URGN)…

URGN

UroGen Pharma

$37.12

0.54 (1.48%)

JNJ

Johnson & Johnson

$137.88

0.345 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 16

    Jul

GIS

General Mills

$51.75

0.01 (0.02%)

08:05
04/23/19
04/23
08:05
04/23/19
08:05
Hot Stocks
General Mills signs 15-year power purchase agreement with Roaring Fork Wind »

General Mills signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

CAMP

CalAmp

$13.48

0.07 (0.52%)

08:05
04/23/19
04/23
08:05
04/23/19
08:05
Hot Stocks
CalAmp partners with Trophy Automotive Dealer Group »

CalAmp has partnered with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

SASR

Sandy Spring Bancorp

$34.06

0.55 (1.64%)

08:04
04/23/19
04/23
08:04
04/23/19
08:04
Conference/Events
Sandy Spring Bancorp management to meet with Stephens »

Group Luncheon with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 13

    May

ET

Energy Transfer LP

$15.58

0.32 (2.10%)

08:03
04/23/19
04/23
08:03
04/23/19
08:03
Hot Stocks
Energy Transfer LP announces resumed operations at Mariner East 1 pipeline »

Energy Transfer LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

BOLD

Audentes Therapeutics

$39.53

0.65 (1.67%)

08:03
04/23/19
04/23
08:03
04/23/19
08:03
Hot Stocks
Audentes Therapeutics launches cGMP plasmid manufacturing facility »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

TROV

Trovagene

$3.29

-0.05 (-1.50%)

, ABBV

AbbVie

$78.10

0.54 (0.70%)

08:03
04/23/19
04/23
08:03
04/23/19
08:03
Hot Stocks
Trovagene announces preclinical data evaluating onvansertib with venetoclax »

Trovagene (TROV)…

TROV

Trovagene

$3.29

-0.05 (-1.50%)

ABBV

AbbVie

$78.10

0.54 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABCB

Ameris Bancorp

$34.77

-0.4 (-1.14%)

, LION

Fidelity Southern

$27.79

-0.29 (-1.03%)

08:02
04/23/19
04/23
08:02
04/23/19
08:02
Hot Stocks
Ameris Bancorp sees FY19 normalized ROTCE 17%-19% »

Ameris Bancorp (ABCB)…

ABCB

Ameris Bancorp

$34.77

-0.4 (-1.14%)

LION

Fidelity Southern

$27.79

-0.29 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 14

    May

NVTA

Invitae

$22.80

-0.065 (-0.28%)

, UNH

UnitedHealth

$227.14

5.4 (2.44%)

08:02
04/23/19
04/23
08:02
04/23/19
08:02
Recommendations
Invitae, UnitedHealth, NeoGenomics, LabCorp, Quest Diagnostics, Opko Health analyst commentary  »

UnitedHealth preferred…

NVTA

Invitae

$22.80

-0.065 (-0.28%)

UNH

UnitedHealth

$227.14

5.4 (2.44%)

NEO

NeoGenomics

$20.00

0.33 (1.68%)

LH

LabCorp

$144.26

-0.94 (-0.65%)

DGX

Quest Diagnostics

$85.17

-0.55 (-0.64%)

OPK

Opko Health

$2.33

-0.075 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 14

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 23

    Jun

  • 06

    Aug

  • 13

    Nov

FB

Facebook

$181.49

3.21 (1.80%)

08:00
04/23/19
04/23
08:00
04/23/19
08:00
Recommendations
Facebook analyst commentary at Credit Suisse »

Signs of potential value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    Jun

ZLAB

Zai Lab

$29.36

0.17 (0.58%)

07:59
04/23/19
04/23
07:59
04/23/19
07:59
Conference/Events
Zai Lab to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

LYFT

Lyft

$60.91

2.6 (4.46%)

07:58
04/23/19
04/23
07:58
04/23/19
07:58
Initiation
Lyft initiated  »

Lyft initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

CDNS

Cadence Design

$64.23

0.87 (1.37%)

07:57
04/23/19
04/23
07:57
04/23/19
07:57
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

WSO

Watsco

$150.99

-0.39 (-0.26%)

07:56
04/23/19
04/23
07:56
04/23/19
07:56
Conference/Events
Watsco management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 30

    Apr

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

07:55
04/23/19
04/23
07:55
04/23/19
07:55
General news
U.S. chain store sales dropped 1.4% in the week ended April 20 »

U.S. chain store sales…

LII

Lennox

$267.77

-2.97 (-1.10%)

07:54
04/23/19
04/23
07:54
04/23/19
07:54
Recommendations
Lennox analyst commentary  »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 23

    May

  • 05

    Jun

  • 13

    Nov

PENN

Penn National

$21.28

0.055 (0.26%)

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Recommendations
Penn National analyst commentary  »

Penn National attractive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

SCRYY

Scor

$0.00

(0.00%)

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Conference/Events
Scor management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Conference/Events
The Board of Governors of the Federal Reserve System to hold a meeting »

The Board of Governors of…

AUTL

Autolus Therapeutics

$26.67

0.09 (0.34%)

07:52
04/23/19
04/23
07:52
04/23/19
07:52
Hot Stocks
Autolus Therapeutics receives orphan drug designation for enriched T-cells »

Autolus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

MDSO

Medidata

$90.30

11.44 (14.51%)

, DASTY

Dassault Systemes

$0.00

(0.00%)

07:52
04/23/19
04/23
07:52
04/23/19
07:52
Downgrade
Medidata, Dassault Systemes rating change  »

Medidata downgraded to…

MDSO

Medidata

$90.30

11.44 (14.51%)

DASTY

Dassault Systemes

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 23

    Jun

AZRX

AzurRx BioPharma

$2.60

0.185 (7.68%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Hot Stocks
AzurRx BioPharma surpasses 50% enrollment for Phase 2 OPTION study »

AzurRx BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

HAL

Halliburton

$31.09

-0.03 (-0.10%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Recommendations
Halliburton analyst commentary at SunTrust »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 15

    May

  • 22

    May

  • 29

    May

  • 13

    Nov

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Hot Stocks
JetBlue sees Q2 effective tax rate of approx. 25% »

JetBlue expects an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 16

    May

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.